| Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary fibrosis M Chilosi, V Poletti, A Zamò, M Lestani, L Montagna, P Piccoli, S Pedron, ... The American journal of pathology 162 (5), 1495-1502, 2003 | 880 | 2003 |
| Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target R Chiarle, WJ Simmons, H Cai, G Dhall, A Zamo, R Raz, JG Karras, ... Nature medicine 11 (6), 623-629, 2005 | 546 | 2005 |
| Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma R Crescenzo, F Abate, E Lasorsa, M Gaudiano, N Chiesa, F Di Giacomo, ... Cancer cell 27 (4), 516-532, 2015 | 498 | 2015 |
| Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death A Zamo, R Chiarle, R Piva, J Howes, Y Fan, M Chilosi, DE Levy, ... Oncogene 21 (7), 1038-1047, 2002 | 498 | 2002 |
| Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome E Chigrinova, A Rinaldi, I Kwee, D Rossi, PMV Rancoita, JC Strefford, ... Blood, The Journal of the American Society of Hematology 122 (15), 2673-2682, 2013 | 327 | 2013 |
| ATM deficiency sensitizes mantle cell lymphoma cells to poly (ADP-ribose) polymerase-1 inhibitors CT Williamson, H Muzik, AG Turhan, A Zamò, MJ O'Connor, DG Bebb, ... Molecular cancer therapeutics 9 (2), 347-357, 2010 | 223 | 2010 |
| Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms R Piva, L Agnelli, E Pellegrino, K Todoerti, V Grosso, I Tamagno, ... Journal of clinical oncology 28 (9), 1583-1590, 2010 | 189 | 2010 |
| KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study S Ferrero, D Rossi, A Rinaldi, A Bruscaggin, V Spina, CW Eskelund, ... Haematologica 105 (6), 1604, 2019 | 169 | 2019 |
| Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM I Álvarez-Twose, R Zanotti, D González-de-Olano, P Bonadonna, A Vega, ... Journal of allergy and clinical immunology 133 (2), 520-528. e5, 2014 | 150 | 2014 |
| Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis M Chilosi, A Zamò, C Doglioni, D Reghellin, M Lestani, L Montagna, ... Respiratory research 7 (1), 95, 2006 | 149 | 2006 |
| Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12 A Rigo, M Gottardi, A Zamò, P Mauri, M Bonifacio, M Krampera, ... Molecular cancer 9 (1), 273, 2010 | 143 | 2010 |
| Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma L Agnelli, E Mereu, E Pellegrino, T Limongi, I Kwee, E Bergaggio, ... Blood, The Journal of the American Society of Hematology 120 (6), 1274-1281, 2012 | 135 | 2012 |
| Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling C Pighi, TL Gu, I Dalai, S Barbi, C Parolini, A Bertolaso, S Pedron, A Parisi, ... Cellular oncology 34 (2), 141-153, 2011 | 122 | 2011 |
| Role of disease‐causing genes in sporadic pancreatic endocrine tumors: MEN1 andVHL PS Moore, E Missiaglia, D Antonello, A Zamò, G Zamboni, V Corleto, ... Genes, Chromosomes and Cancer 32 (2), 177-181, 2001 | 117 | 2001 |
| Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua D Croxatto, A Micheletti, E Montaldo, P Orecchia, F Loiacono, ... Mucosal immunology 9 (6), 1372-1383, 2016 | 111 | 2016 |
| CD 30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis JM Morgado, O Perbellini, RC Johnson, C Teodósio, A Matito, ... Histopathology 63 (6), 780-787, 2013 | 108 | 2013 |
| MicroRNA profiles of t (14; 18)–negative follicular lymphoma support a late germinal center B-cell phenotype E Leich, A Zamo, H Horn, E Haralambieva, B Puppe, RD Gascoyne, ... Blood, The Journal of the American Society of Hematology 118 (20), 5550-5558, 2011 | 104 | 2011 |
| Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis M Rossini, R Zanotti, G Orsolini, G Tripi, O Viapiana, L Idolazzi, A Zamò, ... Osteoporosis International 27 (8), 2411-2421, 2016 | 100 | 2016 |
| ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma C Buske, M Hutchings, M Ladetto, V Goede, U Mey, P Soubeyran, ... Annals of Oncology 29 (3), 544-562, 2018 | 92 | 2018 |
| DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features AJ Arribas, A Rinaldi, AA Mensah, I Kwee, L Cascione, EF Robles, ... Blood, The Journal of the American Society of Hematology 125 (12), 1922-1931, 2015 | 90 | 2015 |
Maurizio LestaniAulss8 VI "ovest vicentino" - Direttore UOC di Anatomia PatologicaVerified email at ulss5.it
